Categories
Par Drugs and Chemicals Limited — Important, 14-05-2026: Updates
14-05-2026 · 06:46 pm
Company's Board approved solid Q4/FY financial results: ₹107.66 Cr revenue & ₹13.11 Cr profit. Strong operating cash flow at ₹16.43 Cr. Greenlit ₹90 Cr for liquid fund investments and renewed a ₹1.61 Cr banking facility. Strategic restructuring faces regulatory delays, yet auditors affirm going concern.
No comments yet. Be the first to comment!